Benzinga | Aug 11, 2020 04:04PM EDT

Arcutis Biotherapeutics Q2 EPS $(0.94) Up From $(4.69) YoY

Arcutis Biotherapeutics (NASDAQ:ARQT) reported quarterly losses of $(0.94) per share. This is a 79.96 percent increase over losses of $(4.69) per share from the same period last year.